Medpace Holdings financials
$622.11+1.00%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $707.3M | $706.6M | $708.5M | $659.9M | $603.3M | $558.6M | $536.6M | $533.3M | $528.1M | $511.0M | $498.4M | $492.5M |
| Gross profit | $201.6M | $196.3M | $205.3M | $196.9M | $180.0M | $178.3M | $178.3M | $169.0M | $153.8M | $155.1M | $498.4M | $492.5M |
| Gross margin | 28.5% | 27.8% | 29.0% | 29.8% | 29.8% | 31.9% | 33.2% | 31.7% | 29.1% | 30.4% | 100.0% | 100.0% |
| Operating income | $146.8M | $141.5M | $153.3M | $141.8M | $126.3M | $113.5M | $125.4M | $112.3M | $105.2M | $104.1M | $87.3M | $84.9M |
| Net income | $121.4M | $123.9M | $135.1M | $111.1M | $90.3M | $114.6M | $117.0M | $96.4M | $88.4M | $102.6M | $78.3M | $70.5M |
| Net margin | 17.2% | 17.5% | 19.1% | 16.8% | 15.0% | 20.5% | 21.8% | 18.1% | 16.7% | 20.1% | 15.7% | 14.3% |
| Diluted EPS | $4.25 | $4.28 | $4.67 | $3.86 | $3.10 | $3.67 | $3.67 | $3.01 | $2.75 | $3.20 | $2.46 | $2.22 |
| EBITDA | $153.5M | $148.4M | $160.4M | $148.9M | $133.3M | $120.5M | $132.9M | $119.8M | $112.4M | $111.1M | $87.3M | $91.8M |
| Operating cash flow | $162.0M | $151.8M | $192.7M | $246.2M | $148.5M | $125.8M | $190.7M | $149.1M | $116.4M | $152.7M | $156.4M | $114.4M |
| Free cash flow | $138.1M | $145.0M | $188.1M | $235.5M | $142.4M | $115.8M | $183.0M | $138.5M | $103.5M | $147.2M | $146.4M | $105.7M |
| Diluted shares | 28.6M | 29.0M | 29.0M | 28.8M | 29.1M | 31.2M | 31.9M | 32.1M | 32.1M | 32.0M | 31.9M | 31.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $502.7M | $652.7M | $497.0M | $285.4M | $46.3M | $441.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $2.06B | $2.13B | $1.98B | $1.75B | $1.57B | $1.90B |
| Total liabilities | $1.62B | $1.53B | $1.52B | $1.46B | $1.40B | $1.30B |
| Shareholders' equity | $433.9M | $598.3M | $459.1M | $293.6M | $172.4M | $593.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology